Click Here To: REGISTER

CGC FACT SHEET

Objectives of THE SECOND CONSUMER GENETICS CONFERENCE:

-          What are the regulatory issues, from a legal standpoint, surrounding this field?  What are the intellectual property considerations regarding panel content and freedom to operate (both in the DTC market, as well as in the current Molecular Diagnostic market)?

o   Hear from the top law firms in the country, about strategies to employ and “gotchas” to avoid.  There will be knowledgeable legal firms, presenting in the Legal Track and present in the exhibit hall that will help guide you through your questions.

-          What should biotechnology companies do to capitalize on the DTC market, as well as do to better interact with the Molecular Diagnostic AND PHARMACEUTICAL marketS?

o   A large number of innovative biotechnology companies will be exhibiting – learn about the cutting edge new technologies that will further biomarker discovery, biomarker validation, and biomarker interrogation.  Hear these technologies presented during the “New Technology” track.  The real needs of DTC companies and Molecular Diagnostic Laboratories will be presented,  throughput needs will be laid out, reagent considerations will be highlighted, and collaboration opportunities will be discussed.  Hear how pharmaceutical companies, interested in Pharmacogenomics, are planning to interact with the DTC market and biotechs.

-          How will physicians interact with their patients who come back with the results from these tests?

o   A number of physicians will be present.  Hear world class doctors' views on DTC, and their plans, if any, to work with DTC companies

-          Will the DTC market change the business structure of laboratories that provide traditional molecular diagnostic testing services?

o   Molecular diagnostic laboratories will be exhibiting.  These labs will also be presenting their current/future capabilities, and thoughts about the fit with the DTC market.  Physicians will have a chance to interact with these laboratories, and hear about how new, cutting edge technologies (at work in diagnostic labs) will give faster, more accurate results.

-          WHAT SECURITY MEASURES SHOULD BE TAKEN TO ENSURE CONSUMER’S PRIVACY WHEN DEALING DIRECTLY WITH THE LABORATORY / COMPANY?

o   Hear from leading experts in patient and consumer security

-          What Public Relation/Business Strategies should be considered to keep companies in a positive public perception?

o   hear about “lessons learned” from other fields that faced public scrutiny.  The top public relations firms will be presenting cases, and examples, of how to navigate these treacherous waters.